Abbott Labs (ABT)
Company | Ticker | Sector | Industry | Quality | PAR |
---|---|---|---|---|
Abbott Labs | ABT | Healthcare | Medical Devices | 94 | 10.7% |
Current Price (08/12) | $111.48 | |||
CAPS Rating (Rate this stock on CAPS) | ![]() |
|||
Expected Income Statement | ||||
Current Sales | 45,548.0 | |||
Sales Growth Forecast | 6.3% | |||
Net Profit Margin | 23.5% | |||
Projected Shares Outstanding | 1,759.38 | |||
EPS - Five year Forecast | $8.26 | |||
Average P/E Ratio | 21.0 | |||
Projected Average Price | $173.42 | |||
Price Appreciation (Annualized) | 9.2% | |||
Annual Dividend Yield | 1.5% | |||
Projected Annual Return | 10.7% | |||
Quality | ||||
Financial Strength | 99 | 24.8 | ||
EPS Stability | 94 | 23.5 | ||
Industry Sales Growth Rate | 11.5% | 6.8 | ||
Industry Net Profit Margin | 15.5% | 19.0 | ||
Calculated Quality Rating | 75.2 | |||
Fool CAPS | ||||
Total Players
2487
Outperforms
97
Underperforms
All-Stars (476)
463
Outperforms (97%)
13
Underperforms
|
||||
Fundamental Data Updated: 05/13/2022 |